nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—midbrain—Gilles de la Tourette syndrome	0.229	0.229	CbGeAlD
Amcinonide—ANXA1—nervous system—Gilles de la Tourette syndrome	0.188	0.188	CbGeAlD
Amcinonide—ANXA1—central nervous system—Gilles de la Tourette syndrome	0.181	0.181	CbGeAlD
Amcinonide—ANXA1—brain—Gilles de la Tourette syndrome	0.144	0.144	CbGeAlD
Amcinonide—NR3C1—midbrain—Gilles de la Tourette syndrome	0.0795	0.0795	CbGeAlD
Amcinonide—NR3C1—nervous system—Gilles de la Tourette syndrome	0.0654	0.0654	CbGeAlD
Amcinonide—NR3C1—central nervous system—Gilles de la Tourette syndrome	0.0629	0.0629	CbGeAlD
Amcinonide—NR3C1—brain—Gilles de la Tourette syndrome	0.05	0.05	CbGeAlD
